Hui-You Lin

Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors

Pei‐Yi Chu, Shih Sheng Jiang, Yan‐Shen Shan et al. · Oncotarget · 2017 · 21 citations · Full text

Medicine, Cell Biology, Oncology +17

The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors

Tsung-Ming Chang, Yan‐Shen Shan, Pei‐Yi Chu et al. · Oncotarget · 2017 · 19 citations · Full text

Medicine, Oncology, Pathology +16

BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of <i>c-KIT</i> –Driven Myeloid Leukemia

Li‐Tzong Chen, Chiung-Tong Chen, Weir-Torn Jiaang et al. · Molecular Cancer Therapeutics · 2016 · 13 citations

Medicine, Oncology, Pharmacology +17

<i>PCK2</i> promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-β/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination

Tsung‐Ming Chang, Wei-Yu Fang, Hui‐Ping Hsu et al. · Cancer Biology & Therapy · 2025 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +17